about
The crystal structure of the extracellular domain of the inhibitor receptor expressed on myeloid cells IREM-1Channels in mitochondrial membranes: knowns, unknowns, and prospects for the future.On the measurement of the functional properties of the CFTR.On the structural organization of the intracellular domains of CFTR.Differential gene expression profiles of two excitable rat cell lines after over-expression of WT- and C121W-β1 sodium channel subunits.Antisense-mediated post-transcriptional silencing of SCN1B gene modulates sodium channel functional expression.Visualization of single proteins from stripped native cell membranes: a protocol for high-resolution atomic force microscopy.Functional modulation of voltage-dependent sodium channel expression by wild type and mutated C121W-β1 subunit.Direct interaction of a CFTR potentiator and a CFTR corrector with phospholipid bilayers.Molecular differential expression of voltage-gated sodium channel α and β subunit mRNAs in five different mammalian cell lines.A quantitative description of the activation and inhibition of CFTR by potentiators: Genistein.Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains.Functional and pharmacological induced structural changes of the cystic fibrosis transmembrane conductance regulator in the membrane solved using SAXS.Molecular dynamics analysis of the wild type and dF508 mutant structures of the human CFTR-nucleotide binding domain 1.A SAXS-based ensemble model of the native and phosphorylated regulatory domain of the CFTR.Identification of an intra-molecular disulfide bond in the sodium channel β1-subunit.Amyloid β-peptide insertion in liposomes containing GM1-cholesterol domainsFunctional analysis of mutations in the putative binding site for cystic fibrosis transmembrane conductance regulator potentiators. Interaction between activation and inhibitionStructure-activity relationship of 1,4-dihydropyridines as potentiators of the cystic fibrosis transmembrane conductance regulator chloride channelSmall-angle X-ray scattering study of the ATP modulation of the structural features of the nucleotide binding domains of the CFTR in solutionA potentiator induces conformational changes on the recombinant CFTR nucleotide binding domains in solutionParametrisation of the free energy of ATP binding to wild-type and mutant Kir6.2 potassium channelsOn the interactions between nucleotide binding domains and membrane spanning domains in cystic fibrosis transmembrane regulator: A molecular dynamic studySmall molecule-facilitated anion transporters in cells for a novel therapeutic approach to cystic fibrosis
P50
Q27643730-E6DED930-4C15-4182-B6D9-7A913DBF10E7Q30195176-D9D5D148-83CF-4E97-AD98-C180A81B9F00Q37279587-61F77343-5C51-4FDF-B325-A293E2CEA4C1Q38186919-7D49194B-D5C4-4A2C-87D6-335C5C2E772EQ38892504-75096E20-A2F5-4E6D-B292-482E4F80F962Q39076979-01544051-730D-4586-9983-F3849EC26E55Q39150844-B0B85F04-9019-45FB-BC0B-C8DDFAF815CAQ39166783-D307C9CE-DF10-4AC2-96A6-F21078ED1097Q39202742-E9958068-188C-4D61-A0FE-BB2FA228C682Q39443518-C4F24E3A-04CA-4EAC-A69D-39B36DFFF89BQ40401974-B72881C3-227E-43FE-ADF4-6582A45BED98Q40456917-6CF002B4-1A4B-460C-88E5-9A844DBC2BB9Q42834943-EE1C0AEA-B81B-4017-8212-3DF5B4A36C51Q43271196-741FFB92-70FC-4051-B232-95662C983D87Q46491265-02244B59-B2F1-4E4A-A2B2-920AE66F6D75Q51760309-AD4056EE-1F8A-40BB-A445-BFCBF1826EF7Q59203935-E5367BC9-5E40-4067-B907-3D1CB9FC3A4AQ79631141-5271C2D1-1FAB-43DA-A3EA-680F76AFF8C4Q80201482-812E6B0D-AE88-41CB-A1BE-3B813B048CA2Q83674996-E168910D-9F39-45AB-A3EA-1857576D69D0Q84509462-08B7D62A-A2C6-42C8-AEE5-925FEDFEB879Q85633972-FD71F72A-6F14-4272-9838-ACE5BAEC1D86Q86637382-C11F5365-01BF-4CEC-BE5C-772EF514E1AEQ92065605-E308BBC7-4039-450F-A9D9-14E570F87B87
P50
description
researcher
@en
wetenschapper
@nl
name
Moran O
@nl
Oscar Moran
@en
type
label
Moran O
@nl
Oscar Moran
@en
altLabel
Moran O
@en
prefLabel
Moran O
@nl
Oscar Moran
@en
P106
P31
P496
0000-0003-1287-6176